Omega Fund Management

Omega Fund Management as of March 31, 2021

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 22 positions in its portfolio as reported in the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Common Stock (REPL) 20.8 $153M 5.0M 30.51
Morphic Holding Common Stock (MORF) 19.6 $144M 2.3M 63.28
Kronos Bio Common Stock 15.2 $112M 3.8M 29.27
Ikena Oncology Common Stock (IKNA) 8.7 $64M 2.2M 28.25
Atea Pharmaceuticals Common Stock (AVIR) 7.1 $52M 847k 61.75
Spruce Biosciences Common Stock 4.9 $36M 2.2M 16.60
Gossamer Bio Common Stock (GOSS) 4.2 $31M 3.3M 9.25
Immunic Common Stock 3.9 $29M 1.8M 15.94
Paratek Pharmaceuticals Common Stock 2.5 $18M 2.6M 7.06
Arcutis Biothereapeutics Common Stock (ARQT) 2.5 $18M 624k 28.93
Checkmate Pharmaceuticals Common Stock 2.2 $16M 1.3M 12.14
Alpine Immune Sciences Common Stock 1.9 $14M 1.3M 10.60
Syros Pharmaceuticals Common Stock 1.6 $12M 1.6M 7.48
ESSA Pharma Common Stock (EPIX) 1.3 $9.8M 337k 29.05
Cidara Therapeutics Common Stock 0.7 $5.3M 2.0M 2.66
Omega Alpha SPAC Class A ordinary shares 0.7 $5.0M 501k 9.98
FibroGen Common Stock 0.6 $4.5M 131k 34.71
Trevi Therapeutics Common Stock (TRVI) 0.5 $3.4M 1.3M 2.71
ObsEva Common Stock 0.4 $3.2M 999k 3.25
Jounce Therapeutics Common Stock 0.4 $2.8M 276k 10.27
Immunocore Holdings Common Stock (IMCR) 0.3 $2.2M 52k 42.57
Pieris Pharmaceuticals Common Stock 0.1 $580k 226k 2.57